Details for New Drug Application (NDA): 021097
✉ Email this page to a colleague
The generic ingredient in VISICOL is sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate profile page.
Summary for 021097
Tradename: | VISICOL |
Applicant: | Salix Pharms |
Ingredient: | sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.398GM;1.102GM | ||||
Approval Date: | Sep 21, 2000 | TE: | RLD: | No |
Expired US Patents for NDA 021097
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Salix Pharms | VISICOL | sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate | TABLET;ORAL | 021097-001 | Sep 21, 2000 | 5,616,346 | ⤷ Try for Free |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription